Yearly Archives: 2023

Mexico Displaces China as the United State’s Largest Trading Partner.

Mexico maintains position as largest trade partner of the US https://www.dallasfed.org/research/economics/2023/0711 https://www.bloomberg.com/graphics/2023-mexico-china-us-trade-opportunity/

Posted in Portfolio Model Subscription

The Pitfall of Cherry Picking.

“Two Heads are better than one.” “It Takes a village to raise a child.” “It takes 2 flints to make a fire.” “If you want to go fast, go alone. If you want to go far, go together“. These quotes

Posted in Open Blog

Grupo Comercial Chedraui (CHDRAUIB-MX, $5.92) to be Added to the S&P/BMV IPC Equity Index Effective 09/18/23.

Effective September 18th, 2023, Grupo Comercial Chedraui will be added to Mexico’s representative equity index covering the top 100 companies in Mexico by market capitalization. Inclusion forces pro-rata equity participation by any passive fund or ETF that seeks to mirror

Posted in Open Blog

Adyen NV (ADYEY-OTC, $8.47 US). An EBITDA Decline Does Not Equate to a Change in my Investment Thesis.

(EU converted to USD at the rate of 1.0868 as of 06/30/2023). Adyen NV, the fast growing publicly traded payment processor, reported a very disappointing first half 2023 fiscal result. Net revenues, at $803.2 million US, increased by 4.4% as

Posted in Open Blog

Novo Nordisk (NVO-NYSE, $187.57) and Eli Lilly (LLY-NYSE, $517.53) Seek to Potentially Upend Modern Preventative Healthcare. There Will be Winners and Losers.

A key study, detailed today, published by Novo Nordisk, confirm what has been widely assumed by medical researchers in the rather new GLP-1 medication class; that in addition to providing quantifiable and fairly immediate benefits for those with type 2

Posted in Open Blog
Recent Comments